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Objectives: Patients undergoing coronary artery bypass grafting often have un-
treated mild to moderate mitral regurgitation. The long-term outcome of these
patients follows an uncertain course. The purpose of this study was to examine the
late outcomes in patients with mild to moderate mitral regurgitation at the time of
isolated coronary artery bypass grafting.
Methods: One hundred sixty-three patients with mild to moderate mitral regur-
gitation at the time of isolated coronary artery bypass grafting were identified
from the prospectively collected cardiovascular database at Sunnybrook and
Women’s College Health Sciences Centre. These patients were matched 1:2 with
patients who had isolated coronary artery bypass grafting without mitral regur-
gitation according to gender, age, left ventricular ejection fraction, New York
Heart Association functional class, vascular disease, diabetes, extent of coronary
disease, and year of surgery. There was 99% complete follow-up. Actuarial
survival and event-free (death, myocardial infarction, stroke, cardiac hospital-
ization, and cardiac reintervention) survivals were compared by log-rank meth-
ods. Cox regression was used to assess the effects of the presence of mitral
regurgitation on late survival and event-free survival. Preliminary postoperative
follow-up echocardiography was available for 49 of the 163 patients with mitral
regurgitation.
Results: There were 489 patients in the matched-cohort study, 163 with mitral
regurgitation and 326 without. The average length of follow-up was 3.37  2.04
years. There was no difference in actuarial survival at 6 postoperative years
(mitral regurgitation 81.0% vs no mitral regurgitation 84.7%, P  .9185).
Event-free survival at 6 years was worse in the mitral regurgitation group
(45.7% vs no mitral regurgitation 64.7%, P  .0258) . Patients with mitral
regurgitation had worse functional status (New York Heart Association class 3-4
20.0%, n  30/150, vs no mitral regurgitation 8.1%, n  25/307, P  .0046).
After the matched variables were controlled for, the hazard ratios associated
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with the presence of mitral regurgitation by Cox regression were 0.958 (P 
.7626) for survival and 1.198 (P  .0333) for event-free survival. The only other
significant predictor of late survival was preoperative intra-aortic balloon pump
insertion (hazard ratio 2.484, P  .0365). Of the patients who underwent
follow-up echocardiography, 30.6% (n  15/49) had progression of mitral
regurgitation to moderate to severe degree at an average of 16.4 postoperative
months.
Conclusion: Overall late survival was not affected by the presence of mild to moderate
degrees of mitral regurgitation in patients undergoing coronary artery bypass grafting.
However, these patients had poorer event-free survival and worse late functional status.
In a subset of patients with echocardiographic follow-up, the postoperative course of
mitral regurgitation was variable, and nearly a third of these patients had worsening
mitral regurgitation. Consideration should be given to repairing moderate mitral regur-
gitation in selected cases to improve long-term quality of life.
Asignificant proportion of patients under-going surgical management of coronaryartery disease have concomitant mitral re-gurgitation (MR).1 It has been previouslyshown that 5% to 8% of patients under-going coronary catheterization have some
degree of MR2. The presence of even mild MR has been
shown to influence late survival after acute myocardial
infarction.3 Among patients with MR after acute myocardial
infarction, it has been shown that most have only mild MR
on echocardiography.4. The 1-year survival of these patients
is much worse than that of those without MR, with only
83% of patients with MR alive at 1 year after infarction,
versus 94% of those without MR.5.
Current American Heart Association guidelines are avail-
able for severe MR and concomitant coronary artery bypass
grafting (CABG), and few surgeons address mild or moderate
MR at the time of CABG, mainly because the addition of a
mitral valve procedure at the time of CABG increases the risk
of surgery.6 Many surgeons prefer to treat MR complicating
ischemic heart disease with isolated CABG alone. In fact,
evidence from Emory University has demonstrated that this
may be an acceptable option, with a reported survival of 77%
at 5 years among patients with moderate ischemic MR treated
with isolated CABG.7 A follow-up comparison study of these
patients compared with a matched cohort without MR also
undergoing CABG showed no differences in late survival as
late as 10 years after the surgery.8 However, there is conflicting
evidence that moderate MR in patients undergoing CABG
only is associated with worse long-term outcome.9 Aklog and
colleagues10 have reported that CABG alone for moderate
ischemic MR leaves many patients with significant residual
MR. Because of these conflicting data, this study was under-
taken to examine the early and late outcomes in patients with
ischemic heart disease and MR of degree 1 to 2 on pre-
operative angiography treated with isolated CABG at Sunny-
brook and Women’s College Health Sciences Centre.
Methods
Study Population
From January 1, 1994, to June 30, 2002, a total of 6443 patients
underwent isolated CABG at Sunnybrook and Women’s College
Health Sciences Centre. Data were prospectively collected on
more than 250 demographic, operative, and outcome variables of
these patients and entered into the divisional research database at
the institution. From the database, 163 patients were found to have
undergone surgery with evidence of 1 to 2MR on preoperative
left ventricular angiography. This corresponds with mild to mod-
erate degrees of MR.11 Where a left ventricular angiogram was
absent, preoperative echocardiogram data was used to determine
the presence of MR. This was done for 8/163 patients. All these
patients had functional MR on preoperative echocardiography of
mild to moderate degree (2 to 3). All identified patients were
included in the study, thus, representing a consecutive series of 163
patients with mild to moderate MR undergoing isolated CABG.
These patients were matched 1:2 (n  326) with patients
undergoing isolated CABG without the presence of MR. The 9
variables chosen for matching were age, gender, the presence of
diabetes mellitus (both type I and type II), extent of coronary artery
disease (single, double, or triple vessel disease), left ventricular
grade (grade 1 left ventricular ejection fraction [LVEF] 60%,
grade 2 LVEF 40%-60%, grade 3 LVEF 20%-40%, grade 4 LVEF
20%), timing of surgery (elective, urgent, or emergency), pre-
operative New York Heart Association (NYHA) functional class,
the presence of renal dysfunction (normal vs dialysis dependent or
preoperative serum creatinine 150 mol/L), and year of opera-
tion.
Follow-up
Follow-up information was obtained for 94% of patients with MR
(n  147/157) and 95% of patients without MR (n  301/317).
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This information was supplemented with data from provincial
health card information to determine mortality among patients who
could not be contacted. This procedure resulted in a total of 99%
complete follow-up information for survival data. There were 2
patients without MR and 3 patients with MR who were unavailable
for follow-up. These cases were treated in each of three ways with
respect to future analyses: (1) they were treated as missing values,
(2) they were treated as events, and (3) they were treated as
nonevents. The final results of the analyses were not significantly
different depending on the statistical management of these pa-
tients; thus for consistency, these patients are always treated as
missing in the analyses presented here.
Statistical Analysis
All analyses were performed with SAS version 8.0 (SAS Institute,
Inc, Cary, NC) for Microsoft Windows XP operating system
(Microsoft Corporation, Redmond, Wash) on a desktop computer
system. Continuous data were compared with 2-tailed paired Stu-
dent t tests; categoric data were analyzed with 2 or Fisher exact
statistics. Conditional maximum likelihood estimation of parame-
ters was used to obtain estimates of odds ratios for risk factors for
perioperative events. Survival data were compared with log-rank
methods, and proportional hazards analyses were used for multi-
variable adjustment of late outcomes.
Results
Table 1 shows the demographic characteristics of patients
with mild to moderate MR compared with a concurrent
group of patients from the same period undergoing isolated
CABG with no MR. The patients with MR were older, more
likely to be female, had a higher incidence of renal dys-
function, had poorer ventricular function and preoperative
functional status, and had a higher incidence of triple-vessel
disease than patients without MR. The preoperative charac-
teristics shown in Table 1 were used to match the study
cohort.
The operative results and data are shown in Table 2,
comparing patients with CABG and mild to moderate MR
(n  163) with the group of matched patients undergoing
CABG without MR (n  326). It can be observed from this
table that in terms of basic perioperative data and early
postoperative results, no significant differences were found
between patients with MR and those matched patients with-
out MR.
TABLE 2. Operative data: Comparison of patients undergo-
ing CABG with and without mild to moderate MR
No MR
(n  326)
MR
(n  163) P value
No. of grafts (mean  SD) 3.21 0.90 3.38 0.76 .5767
Arterial grafts (mean  SD) 1.30 0.73 1.24 0.73 .5556
Internal thoracic artery use
(%)
91.1% 89.0% .4672
Crossclamp time (min, mean
 SD)
79 32 73 26 .001
Cardiopulmonary bypass time
(min, mean  SD)
103 41 92 28 .001
Incomplete revascularization
(%)
12.3% 14.0% .5927
Mortality (%) 2.8% 3.5% .8611
Perioperative myocardial
infarction (%)
1.8% 4.0% .2027
Stroke (%) 2.4% 4.0% .3737
Low output syndrome/intra-
aortic balloon pump (%)
14.6% 17.5% .2718
TABLE 1. Patient demographic data
Characteristic
No MR, entire
cohort
(n  6236)
No MR, matched
group
(n  326)
MR study
group
(n  163) P value*
Age (y, mean  SD) 63  10 65  10 66  10 .0001
Age 70 y (%) 29.5% 45.7% 45.7% .0001
Female (%) 22.7% 34.2% 34.2% .0001
Diabetes mellitus (%) 24.7% 22.6% 22.6% .2394
Peripheral vascular or cerebrovascular disease (%) 20.8% 22.2% 23.2% .1223
Renal dysfunction (%) 2.8% 4.9% 4.9% .0012
Chronic obstructive pulmonary disease (%) 4.9% 5.2% 5.5% .3455
Left ventricular grade 3–4 (%) 20.3% 44.5% 44.5% .0001
NYHA functional class 3–4 (%) 23.5% 89.0% 89.0% .0001
Recent myocardial infarction (%) 8.3% 18.3% 16.3% .0001
Disease extent (%) .0001
Single-vessel disease 6.0% 2.5% 1.2%
Double-vessel disease 27.3% 22.5% 23.8%
Triple-vessel disease 66.7% 75.0% 75.0%
Left main disease 35.1% 24.4% 24.4%
*Values shown are for MR study group versus patients without MR in the entire cohort. Comparisons of MR study group versus matched group without
MR did not reach significance because of matching selection.
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Figures 1 and 2 demonstrate the late functional status of
patients in both groups. In Figure 1, patients with MR had
a higher incidence of NYHA functional class 3 or 4 than do
patients without MR (20.0% vs 8.1%, P  .0046) at a mean
follow-up of 3.4  2.0 years. When analyzed by actual
degree of MR, as shown in Figure 2, an increase in NYHA
Figure 1. Late functional status. Patients with mild to moderate MR (MR) at isolated CABG had poorer late
functional status than those without (MR). Twenty percent of patients with MR were in late NYHA functional
class 3 or 4, compared with 8.2% of patients without MR (P  .0046).
Figure 2. Late functional status by severity of MR. Increasing degree of MR at isolated CABG was associated with
trend toward increasing late NYHA functional class (P  .0042).
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class was observed as the degree of MR increased from
absent (MR0, 8.1%) to mild (MR1, 10.5%) to moderate
(MR2, 23.5%, P  .0042).
Overall patient survival, as shown in Figure 3, was found
to be similar in patients with MR and without MR at late
follow-up. Patients with MR had a 6-year survival of 81.0%,
Figure 3. Late survival. There was no difference in late survival (mean follow-up 3.4  2.0 years) between groups
with (MR) and without (MR) MR as late as 6 years after surgery.
Figure 4. Late event-free survival. There was better late event-free survival among patients without MR (MR) at
isolated CABG. Event-free survival was 64.7% in patients without MR, compared with 36.8% in patients with MR
(MR, P  .0258).
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versus 84.5% among patients without MR (P  .9185).
Survival of the overall patient cohort of patients undergoing
isolated CABG during the same period as the study patients
was significantly better at 6 years (90.7%, P  .0001) than
the survival of either subgroup (Figure 3), reflecting the
presence of important comorbidities.
The late event-free survivals are shown in Figures 4 and
5. Figure 4 shows event-free survival to be much worse in
patients with MR (36.8%) than in a matched cohort of
patients without MR (64.7%, P  .0258). In Figure 5,
patients with mild MR (n  44) were included with the
patients without MR (n 370 total); the event-free survival
of patients with moderate MR (n  119) was significantly
worse (MR2 34.0% vs MR01 48.4%, P  .0415). When
survival was analyzed by individual MR severity, a trend
toward a significant difference in event-free survival was
observed for mild (44.7%) versus moderate MR (34.0%,
P  .0745).
Cox regression was used to determine the effect of MR
severity on late survival and event-free survival. The hazard
ratios associated with the presence of MR were 0.958 (P 
.7626) for overall survival and 1.198 (P  .0333) for
event-free survival. Thus the presence of mild to moderate
MR was not significantly associated with poorer overall
survival but was significant in predicting poorer event-free
survival.
The causes for late hospitalization are shown in Table 3.
Of the patients with MR, 80.4% had no hospitalization
during follow-up, compared with 92.5% of patients without
MR. The increased rate of hospitalization seen in patients
with MR could be accounted for by the higher incidence of
congestive heart failure (11.6% with MR vs 1.8% without,
odds ratio 7.14, P  .0001). Other causes for late hospital-
ization in both groups included atrial fibrillation, amputa-
tion for peripheral vascular ischemia, angina, myocardial
infarction, deep venous thrombosis, pneumonia, stroke, syn-
cope, and intermittent claudication.
Figure 5. Late event-free survival by severity of MR. Patients with 2 MR had significantly worse late event-free
survival than did patients with either absent MR or 1 MR combined (34.0% vs 48.3%, P  .0415).
TABLE 3. Causes of hospitalization in follow-up of patients
with or without MR after isolated CABG
Reason for admission
No MR
(n  281)
MR
(n  138)
No. % No. %
No hospitalization 260 92.5 111 80.4
Congestive heart failure 5 1.8 16 11.6
Atrial fibrillation 2 0.7 1 0.7
Amputation 0 0 2 1.5
Unstable angina pectoris 3 1.1 4 2.9
Myocardial infarction 0 0 3 2.17
Stroke 1 0.4 1 0.7
Deep venous thrombosis 1 0.4 0 0
Pneumonia 5 1.8 0 0
Peripheral vascular disease 1 0.4 0 0
Syncope 3 1.1 0 0
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Follow-up echocardiography was performed in 49 cases
in the MR group at a mean of 16.2  20.5 postoperative
months. The results of these follow-up studies are shown in
Figure 6. Among the 49 patients tested, 30.6% (n  15)
showed progression to moderate to severe MR at the time of
the follow-up study. Of the 15 patients with moderate to
severe MR on late echocardiography, 47% (n  7) had
required hospitalization for congestive heart failure, com-
pared with 2.9% (n  1) of the 34 patients with mild (or
less) MR (P  .0001)
Discussion
Traditionally, patients with mild to moderate MR have not
been considered for combined mitral valve repair and
CABG. The finding of 1 to 2 MR when viewing a
preoperative angiogram in patients with a history of myo-
cardial infarction and depressed ventricular function has
been considered incidental, without much influence on late
patient outcomes. This study was born of an uncertainty
with respect to the management of these patients. There is a
lack of evidence in the literature addressing the late out-
comes in patients with incidental findings of MR on ven-
triculography.
The Society of Thoracic Surgeons database collects in-
formation on the results of surgery after various procedures
from participating centers across North America. The risk
for increased morbidity and mortality of surgery after com-
bined CABG and mitral repair procedures is approximately
twice the risk after isolated CABG. However, these results
include patients undergoing emergency procedures for acute
MR. In addition, patients with severe MR are included in
the cohort. Despite these concerns, most surgeons consider
the risk of a combined procedure too high for what is
considered a relatively benign finding of mild to moderate
MR.
Literature does exist on the survival of patients with
moderate (3 on echocardiography) MR undergoing iso-
lated CABG, as well as combined mitral valve repair and
coronary surgery. Aklog and colleagues10 have shown that
in patients with moderate ischemic MR, treatment with
isolated CABG alone results in significant residual MR.
Furthermore, their data from 38 patients with established
3 ischemic MR on preoperative assessment who also
underwent intraoperative transesophageal echocardiography
suggested a significant risk of underestimation of the degree
of MR solely from intraoperative assessment.
The Emory University group has reported on a cohort of
58 patients operated on between 1977 and 1983 at 5 and 10
years of follow-up. These patients all had moderate MR,
and the group was not able to demonstrate a significant
difference in survival between patients with and without
MR treated with isolated CABG. Significantly, the cohort of
patients being reported on were slightly younger than those
in this study (63 years vs 66 years) and had significantly
better preoperative functional status, with only 10% of
patients in NYHA class 3 or 4 versus 89% in his study. Data
were not given with respect to the late functional status of
these patients, nor to freedom from cardiovascular related
morbidity in follow-up.7,8
Figure 6. Degree of MR on follow-up echocardiography. Postoperative echocardiograms were available for 49
patients with evidence of mild to moderate MR at isolated CABG. Of these, 15 (30.6%) had moderate to severe MR
at follow-up echocardiography. Mean follow-up time was 16.2  20.5 months.
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In a recent study from Yale,12 patients with severe ven-
tricular dysfunction and mild to moderate (1 to 3 on
preoperative echocardiography) MR treated with isolated
CABG had marked improvement in postoperative ventric-
ular function with a decrease in MR. The degree of MR had
decreased from 1.73 to 0.54 at a mean of approximately 3
years after the operation. The mean NYHA class improved
from 3.3 to 1.8. The average preoperative LVEF in these
patients was only 22%. These patients may represent an
extreme in terms of cardiovascular risk; the 5-year survival
of 50% suggests that these are indeed very ill patients.
In studies from Cedars-Sinai Hospital,9 a combined su-
ture mitral annuloplasty and CABG in patients with mod-
erate ischemic MR resulted in significant improvement in
MR after the operation relative to treatment with CABG
alone. However, there was no difference in overall late
survival between treatment arms, and there was a high
incidence of late failure of the suture annuloplasty to control
MR, with 25% of patients with suture annuloplasty having
significant MR on late follow-up.
Prifti and associates13 reported on a study of 99 patients
with mild or moderate ischemic MR grouped into four
treatment arms. The 3-year cumulative mortality among
patients with moderate MR treated with CABG alone was
59%, significantly higher than that among patients with
moderate MR treated with CABG and mitral repair or
among patients with only mild degrees of MR whether
treated with CABG alone or with a combined procedure.
This study also showed that there was a significant increase
in mortality from adding simple annuloplasty repairs to
patients undergoing coronary surgery.
In our study, overall survival among these patients was
not affected by the presence of MR when compared with a
matched cohort of patients without MR. However, the late
event-free survival and late functional status were signifi-
cantly poorer in patients with MR. Twenty percent of pa-
tients with MR are in NYHA functional class 3 or 4 in late
follow-up, compared with only 8.1% of patients without
MR. When only patients with 2 MR on preoperative
ventriculography are included in the analyses, the incidence
of poor late functional status is 23.5%.
A closer examination of the reasons for late hospitaliza-
tion reveals that untreated MR at the time of isolated CABG
results in a significantly higher incidence of hospitalization
for congestive heart failure, atrial fibrillation, syncope, and
stroke. The significant difference in late event-free survival
seen in patients with MR treated by CABG alone can be
accounted for by the increased incidence of congestive heart
failure in these patients. Late echocardiography demon-
strated that of 8 patients admitted for congestive heart
failure, 87.5% (n  7) had moderate to severe MR. Thus it
would appear that the presence of mild to moderate MR on
preoperative ventriculography is not simply an incidental
finding but one that may have a significant impact on late
functional status and quality of life.
What should the operative strategy be for these patients?
The goal of surgical therapy is not only to improve late
survival but also to improve late functional status and late
quality of life. However, these goals should be achieved
without increasing perioperative morbidity and mortality.
An appropriate strategy for the management of 1 to 2
MR discovered on preoperative ventriculography should be
to first establish the degree of MR by preoperative echocar-
diographic assessment of the mitral valve apparatus. If a
patients is found to have only a trivial or mild degree of MR
on preoperative echocardiography, then that patients should
be treated with isolated CABG. If a moderate or severe
degree of MR is established by preoperative echocardio-
graphic assessment, however, then the patient should be
considered for mitral valve repair. This data suggests that
low-risk patients with moderate MR should strongly be
considered for combined mitral valve repair and CABG if
this can be accomplished without an increase in operative
morbidity or mortality.
Limitations of this study include its nature as a retro-
spective matched cohort analysis. Although techniques of
multivariable analysis may adequately control for measur-
able biases, unmeasured bias may still have a strong influ-
ence on the presented results. Another limitation of this
study is the question on which it was based. The criterion
standard for assessment of mitral valve disease is preoper-
ative echocardiography; however, the problem presented in
this article is what is commonly encountered in clinical
practice. Patients are often referred for isolated CABG when
only a coronary angiogram and left ventriculogram have
been performed. The purpose of this study was to determine
the outcomes in patients with an incidental finding of mild
to moderate MR on left ventriculography.
It should be noted that this study does not prove that
adding a mitral valve procedure at the time of isolated
CABG to treated concurrent mild to moderate MR is ben-
eficial. What is needed is a study, preferably a randomized
clinical trial, that could compare the treatment algorithms of
isolated CABG and CABG with mitral valve procedure.
In conclusion, patients with mild to moderate degrees of
MR on preoperative ventriculography have a similar overall
survival to patients without MR but a poorer event-free
survival, poorer late functional status, and higher incidence
of hospitalization for congestive heart failure. The finding of
mild to moderate MR therefore should not be treated as an
incidental finding but should be further evaluated with pre-
operative echocardiographic assessment. The nature and
degree of MR, as well as the patient risk profile, should
guide the further management of these patients.
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Discussion
Dr Frank W. Sellke (Boston, Mass). With patients with moderate
MR, I tend to fix it if they have symptoms related to congestive
heart failure and leave it alone if they don’t have symptoms related
to congestive heart failure. Do you think that is a reasonable
approach? How do you decide whether to repair the MR at the time
of surgery?
Dr Mallidi. As you can see from our study, 90% of the patients
in this study had heart failure symptoms.
Dr Sellke. At the time of surgery?
Dr Mallidi. At the time of surgery or within 1 month before
surgery. So I think one way that you can interpret the study is that
for patients who have heart failure and have moderate MR but are
maybe at high risk for other reasons, such as low LVEF or some
other reason, you can look at the study and say that these patients
do fairly well in the late follow-up with isolated CABG. On the
other hand, if you have a low-risk patient with symptoms of heart
failure and moderate MR, then perhaps it might be worthwhile to
consider a mitral valve repair.
Dr Sellke. How about somebody with mild MR with shortness
of breath; would you fix that?
Dr Mallidi. No.
Dr Robert A. Dion (Leiden, The Netherlands). In this category
of patients with fluctuating or intermittent MR, did you perform a
dynamic test? We have been doing that for about 10 years now in
our institution, and it helps distinguish between people that do not
really need mitral valve repair and those who do. We do an
intraoperative test with a filling test and an afterload test if we still
have a doubt. Did you ever consider for this category of patient to
use a dynamic test to see what happens with MR?
Dr Mallidi. Our study was mainly focused on the question of
the patient referred for CABG who has mild to moderate MR when
you look at the films. We certainly think that dynamic testing may
be helpful in further or fully evaluating these patients to help
determine whether you need to operate on the mitral valve, but
none of these patients had that sort of testing.
Dr Hormoz Azar (Norfolk, Va). Excellent study, congratula-
tions. Considering the divergence of the curves starting around 3.5
with symptoms, do you think that if these survival curves are
carried longer that you are going to start seeing divergence in
survival as well?
Dr Mallidi. That is an excellent question. Certainly we think
that up to 6 years there was no difference in survival, but, as you
mentioned, the symptoms started to develop 2 to 3 years after
surgery, and this may result in late deaths or death between 5 and
10 years among patients with heart failure, most of whom had MR.
So that is certainly a possibility.
Dr Ralph J. Damiano, Jr (St Louis, Mo). One of the weak-
nesses of the study is the fact that you used ventriculography,
which is notoriously inaccurate in grading MR and often quite at
variance with echocardiography. The other problem is that most of
your follow-up is with echocardiography.
Do you have any data for the few patients for whom you had
both echocardiography and ventriculography to show how accu-
rate the preoperative ventriculogram was in grading the MR? I am
interested in what percentage of patients actually had worsening
with time. You may not have those data, but I think it is an
interesting point that maybe would further support your hypothe-
sis.
Dr Mallidi. We had preoperative echocardiographic and ven-
triculographic data available for about 35 patients. In those patients
we continued to use the ventriculographic assessment for the
purposes of the study, just to be consistent, but we did compare the
findings of echocardiography and ventriculography. What we
found was that among patients with 1 or 2 MR according to
ventriculography, none of the patients had severe MR on echocar-
diography, and most of the patients had mild to moderate MR on
echocardiography. However, a few patients had trivial or absent
MR; out of the 35, I think there were 5 or 6 patients with absent
or trivial MR. So we still would have included most patients in our
study. It is absolutely true that a ventriculogram is not the best
assessment. That is why of our first recommendation is that when
you see this finding you should not ignore it, but investigate it with
echocardiography.
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